(VIANEWS) – Riot Blockchain (RIOT), Taiwan Semiconductor (TSM), GlaxoSmithKline (GSK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Riot Blockchain (RIOT)
110.9% sales growth and 8.06% return on equity
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-0.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.06%.
Moving Average
Riot Blockchain’s worth is way below its 50-day moving average of $11.60 and way under its 200-day moving average of $12.41.
Yearly Top and Bottom Value
Riot Blockchain’s stock is valued at $9.10 at 16:22 EST, way under its 52-week high of $20.65 and way higher than its 52-week low of $7.80.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 23.5% and 72%, respectively.
2. Taiwan Semiconductor (TSM)
32.2% sales growth and 25.33% return on equity
Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others. The company also offers customer and engineering support services; manufactures masks; and invests in technology start-up companies; researches, designs, develops, manufactures, packages, tests, and sells color filters; and provides investment services. Its products are used in high performance computing, smartphones, Internet of things, automotive, and digital consumer electronics. The company was incorporated in 1987 and is headquartered in Hsinchu City, Taiwan.
Earnings Per Share
As for profitability, Taiwan Semiconductor has a trailing twelve months EPS of $5.05.
PE Ratio
Taiwan Semiconductor has a trailing twelve months price to earnings ratio of 28.22. Meaning, the purchaser of the share is investing $28.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.33%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2024, the estimated forward annual dividend rate is 2.05 and the estimated forward annual dividend yield is 1.45%.
3. GlaxoSmithKline (GSK)
14.2% sales growth and 38.78% return on equity
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $3.04.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 13.38. Meaning, the purchaser of the share is investing $13.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.78%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 30.74B for the twelve trailing months.
Yearly Top and Bottom Value
GlaxoSmithKline’s stock is valued at $40.66 at 16:22 EST, way under its 52-week high of $45.93 and way higher than its 52-week low of $33.33.
Moving Average
GlaxoSmithKline’s value is under its 50-day moving average of $42.33 and above its 200-day moving average of $38.60.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 16, 2024, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 3.35%.
4. Southwest Airlines (LUV)
6.8% sales growth and 3.84% return on equity
Southwest Airlines Co. operates as a passenger airline company that provides scheduled air transportation services in the United States and near-international markets. As of December 31, 2023, the company operated a total fleet of 817 Boeing 737 aircraft; and served 121 destinations in 42 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as ten near-international countries, including Mexico, Jamaica, the Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. It also provides inflight entertainment and connectivity services on Wi-Fi enabled aircraft; and Rapid Rewards loyalty program that enables program members to earn points for dollars spent on Southwest base fares. In addition, the company offers a suite of digital platforms to support customers' travel needs, including websites and apps; and SWABIZ, an online booking tool. Further, it provides ancillary services, such as Southwest's EarlyBird Check-In, upgraded boarding, and transportation of pets and unaccompanied minors. Southwest Airlines Co. was incorporated in 1967 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Southwest Airlines has a trailing twelve months EPS of $0.76.
PE Ratio
Southwest Airlines has a trailing twelve months price to earnings ratio of 36.24. Meaning, the purchaser of the share is investing $36.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.84%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 52.3% and positive 7.9% for the next.
Volume
Today’s last reported volume for Southwest Airlines is 10408400 which is 23.23% above its average volume of 8446160.
